|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.04 EUR | -0.18% |
|
-1.22% | +6.98% |
| 07-30 | Merck, Wellcome partner with global health group to make Ebola vaccine for clinical trials | RE |
| 07-28 | Atea Pharmaceuticals Says Combination Drug Meets Endpoints in Phase 3 Hepatitis C Trial | MT |
Quotes 5-day view: Gilead Sciences, Inc.
Delayed Quote Deutsche Boerse AG
| 2026-07-27 | 2026-07-28 | 2026-07-29 | 2026-07-30 | 2026-07-31 | |
|---|---|---|---|---|---|
| Last | €115.00 | €117.86 | €117.56 | €113.24 | €113.04 |
| Volume | 175 | 90 | 30 | 125 | 700 |
| Change | +0.49% | +2.49% | -0.25% | -3.67% | -0.18% |
| Opening | €113.86 | €114.76 | €117.92 | €115.66 | €113.82 |
| High | €115.60 | €117.86 | €117.92 | €115.66 | €114.34 |
| Low | €113.56 | €114.76 | €117.56 | €113.24 | €113.04 |
Performance
| 1 day | -0.18% | ||
| 1 week | -1.22% | ||
| 1 month | +1.97% | ||
| 3 months | +3.08% | ||
| 6 months | -4.38% | ||
| Current year | +6.98% | ||
| 1 year | +12.43% | ||
| 3 years | +62.55% | ||
| 5 years | +95.77% | ||
| 10 years | +58.27% |
Volumes
marketsDaily volume
700
Estimated daily volume
700
Avg. Volume 20 sessions
241
Daily volume ratio
2.9
Avg. Volume 20 sessions
27,242.64
Avg. Volume 20 sessions USD
31,405.32
Record volume 1
88,108
Record volume 2
70,676
Record volume 3
50,862
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
161,664,813,293
Market Cap (USD)
161,664,813,293
Net sales (USD)
29,443,000,000
Number of employees
17,000
Sales / Employee (USD)
1,731,941
Free-Float
99.88 %
Free-Float capitalization (EUR)
185,745,163,399
Free-Float capitalization (USD)
161,468,270,543
Average Daily Capital Traded
0%
Indicators
Moving average 5 days
115.62
Moving average 20 days
115.49
Moving average 50 days
112.84
Moving average 100 days
115.04
Price spread / (MMA5)
+2.28%
Price spread / (MMA20)
+2.17%
Price spread / (MMA50)
-0.18%
Price spread / (MMA100)
+1.77%
RSI 9 days
43.9
RSI 14 days
47.38
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.18% | -1.22% | +12.43% | +62.55% | 162B | |
| -0.53% | -3.95% | +55.23% | +152.74% | 1,024B | |
| +0.21% | -2.68% | +55.61% | +53.02% | 618B | |
| -2.51% | -3.25% | +32.76% | +67.76% | 443B | |
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | |
| -0.14% | -0.24% | +34.41% | +39.01% | 297B | |
| -0.69% | -0.30% | +11.55% | +12.93% | 264B | |
| -7.37% | -4.40% | -2.54% | -43.87% | 209B | |
| -0.64% | +2.43% | +30.52% | +64.49% | 208B | |
| +0.40% | +1.92% | +7.39% | -30.64% | 143B | |
| Average | -1.14% | -1.32% | +27.49% | +40.87% | 371.63B | |
| Weighted average by Cap. | -0.91% | -1.99% | +37.86% | +68.61% |
Historical Quotes: Gilead Sciences, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
11c.4rDOl_yYp1OrHeaY2OR3qg4ZgHQ0cSWCurikEjlyHCI.msaW3Mnd1ybZdKPouoMTnlxP6yR8K0HM7-vWP3M4XVaAhqHyiO74I_5ZgQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 12:24:05 | 113.04 | 50 | 700 |
| 08:02:06 | 114.34 | 30 | 650 |
| 07:11:24 | 113.30 | 245 | 620 |
Course Extremes
| 1 week | 113.04 |  | 117.92 |
| 1 month | 110.42 | | 121.2 |
| Current year | 100.42 | | 132 |
| 1 year | 93.42 | | 132 |
| 3 years | 57.58 | | 132 |
| 5 years | 52.23 | | 132 |
| 10 years | 46.23 | | 132 |
Monthly variations
Annual variations
| 2026 | +6.98% | ||
| 2025 | +17.62% | ||
| 2024 | +22.89% | ||
| 2023 | -7.93% | ||
| 2022 | +22.27% | ||
| 2021 | +40.32% | ||
| 2020 | -21.36% | ||
| 2019 | +6.75% | ||
| 2018 | -9.10% | ||
| 2017 | -11.50% | ||
| 2016 | -27.13% | ||
| 2015 | +17.35% | ||
| 2014 | +48.14% | ||
| 2013 | +96.64% | ||
| 2012 | +75.73% | ||
| 2011 | +13.52% | ||
| 2010 | +1.45% |
- Stock Market
- Stocks
- GILD Stock
- GIS Stock
- Quotes Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
